TargetMol

TargetMol logo

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, specializing in chemical and biological research products and service to meet the research needs of global customers. With the help of fast and efficient global supply chain,professional and rigorous procurement process and timely dynamic news of products, you will save more time with less cost and lead in drug discovery and screening. We are equipped to meet an array of client’s requirements, varying from virtual screening to chemical structure optimization to the provision of commercial products. For further information on our products and services, take a look around our website.

Company Website

Product Listing

(20S)-Protopanaxadiol 5mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 10mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 25mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 50mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 100mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 200mg  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(20S)-Protopanaxadiol 10mM * 1mL (in DMSO)  | 98.91%

TargetMol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

More Information Supplier Page

(2S)-Protopanaxatriol 5mg  | 98.80%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(2S)-Protopanaxatriol 10mg  | 98.80%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(2S)-Protopanaxatriol 25mg  | 98.80%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(2S)-Protopanaxatriol 50mg  | 98.80%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(2S)-Protopanaxatriol 100mg  | 98.80%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(2S)-Protopanaxatriol 10mM * 1mL (in DMSO)  | 98.80%

TargetMol

(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.

More Information Supplier Page

(E/Z)-4-hydroxy Tamoxifen 10mg  | 98.00%

TargetMol

4-Hydroxytamoxifen is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer.

More Information Supplier Page

(E/Z)-4-hydroxy Tamoxifen 25mg  | 98.00%

TargetMol

4-Hydroxytamoxifen is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer.

More Information Supplier Page

(E/Z)-4-hydroxy Tamoxifen 50mg  | 98.00%

TargetMol

4-Hydroxytamoxifen is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer.

More Information Supplier Page

(E/Z)-4-hydroxy Tamoxifen 10mM * 1mL (in DMSO)  | 98.00%

TargetMol

4-Hydroxytamoxifen is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer.

More Information Supplier Page

(R)-(+)-Atenolol 10mM * 1mL (in DMSO)  | 98.00%

TargetMol

(R)-(+)-Atenolol is a cardioselective beta-1 adrenergic blocker, which properties are similar to propranolol, but without a negative inotropic effect.

More Information Supplier Page

(R)-(+)-Atenolol 10mg  | 98.00%

TargetMol

(R)-(+)-Atenolol is a cardioselective beta-1 adrenergic blocker, which properties are similar to propranolol, but without a negative inotropic effect.

More Information Supplier Page

(R)-(+)-Atenolol 25mg  | 98.00%

TargetMol

(R)-(+)-Atenolol is a cardioselective beta-1 adrenergic blocker, which properties are similar to propranolol, but without a negative inotropic effect.

More Information Supplier Page

(R)-(+)-Atenolol 50mg  | 98.00%

TargetMol

(R)-(+)-Atenolol is a cardioselective beta-1 adrenergic blocker, which properties are similar to propranolol, but without a negative inotropic effect.

More Information Supplier Page

(R)-GNE-140 10mM * 1mL (in DMSO)  | 95.46%

TargetMol

(R)-GNE-140 is an effective LDHA/LDHB inhibitor (IC50s: 3/5 nM) and is 18-fold more potent than S enantiomer.

More Information Supplier Page

(R)-Lansoprazole 50mg  | 98.09%

TargetMol

Dexlansoprazole is the R-isomer of lansoprazole and a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity.

More Information Supplier Page

(R)-Lansoprazole 100mg  | 98.09%

TargetMol

Dexlansoprazole is the R-isomer of lansoprazole and a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity.

More Information Supplier Page

(R)-Lansoprazole 200mg  | 98.09%

TargetMol

Dexlansoprazole is the R-isomer of lansoprazole and a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity.

More Information Supplier Page

(R)-Lansoprazole 500mg  | 98.09%

TargetMol

Dexlansoprazole is the R-isomer of lansoprazole and a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity.

More Information Supplier Page

(R)-Lansoprazole 10mM * 1mL (in DMSO)  | 98.09%

TargetMol

Dexlansoprazole is the R-isomer of lansoprazole and a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity.

More Information Supplier Page

(R)-Naproxen 5mg  | 99.94%

TargetMol

(R)-Naproxen, an anti-inflammatory agent, has antipyretic and analgesic properties. Both the acid and its sodium salt are used in the therapy of acute gout or dysmenorrhea, musculoskeletal disorders, rheumatoid arthritis and other rheumatic.

More Information Supplier Page

(R)-Naproxen 10mg  | 99.94%

TargetMol

(R)-Naproxen, an anti-inflammatory agent, has antipyretic and analgesic properties. Both the acid and its sodium salt are used in the therapy of acute gout or dysmenorrhea, musculoskeletal disorders, rheumatoid arthritis and other rheumatic.

More Information Supplier Page

(R)-Naproxen 25mg  | 99.94%

TargetMol

(R)-Naproxen, an anti-inflammatory agent, has antipyretic and analgesic properties. Both the acid and its sodium salt are used in the therapy of acute gout or dysmenorrhea, musculoskeletal disorders, rheumatoid arthritis and other rheumatic.

More Information Supplier Page

(R)-Naproxen 50mg  | 99.94%

TargetMol

(R)-Naproxen, an anti-inflammatory agent, has antipyretic and analgesic properties. Both the acid and its sodium salt are used in the therapy of acute gout or dysmenorrhea, musculoskeletal disorders, rheumatoid arthritis and other rheumatic.

More Information Supplier Page

(R)-Naproxen 200mg  | 99.94%

TargetMol

(R)-Naproxen, an anti-inflammatory agent, has antipyretic and analgesic properties. Both the acid and its sodium salt are used in the therapy of acute gout or dysmenorrhea, musculoskeletal disorders, rheumatoid arthritis and other rheumatic.

More Information Supplier Page